Cargando…
The soluble form of BMPRIB is a novel therapeutic candidate for treating bone related disorders
Bone morphogenetic proteins (BMPs) are multi-functional growth factors that belong to the TGF-beta superfamily. Recently, several soluble BMP receptors, such as ActRIIA-Fc, ActRIIB-Fc, and ALK1-Fc, are undergoing clinical trials. Both BMPRIA and BMPRIB are type I BMP receptors, and while BMPRIA-Fc h...
Autores principales: | Yamawaki, Kengo, Kondo, Yuichiro, Okada, Tsutomu, Oshima, Takeshi, Kakitani, Makoto, Tomizuka, Kazuma |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4702141/ https://www.ncbi.nlm.nih.gov/pubmed/26732094 http://dx.doi.org/10.1038/srep18849 |
Ejemplares similares
-
Adult-Specific Systemic Over-Expression Reveals Novel In Vivo Effects of the Soluble Forms of ActRIIA, ActRIIB and BMPRII
por: Yamawaki, Kengo, et al.
Publicado: (2013) -
Low expression of BMPRIB indicates poor prognosis of breast cancer and is insensitive to taxane-anthracycline chemotherapy
por: Dai, Kun, et al.
Publicado: (2015) -
Effects of New Mutations in BMPRIB, GDF9, BMP15, LEPR, and B4GALNT2 Genes on Litter Size in Sheep
por: Ji, Xuewen, et al.
Publicado: (2023) -
The Wnt agonist R-spondin1 regulates systemic graft-versus-host disease by protecting intestinal stem cells
por: Takashima, Shuichiro, et al.
Publicado: (2011) -
Novel anticarcinoembryonic antigen antibody–drug conjugate has antitumor activity in the existence of soluble antigen
por: Shinmi, Daisuke, et al.
Publicado: (2017)